Assets (1 total) 1 Total Assets
0 Approved
1 Phase 3 / Filed
0 Phase 1–2 / Early
2 Diseases
Disease: All diseases (1) Chronic Kidney Disease (1) Myelodysplastic Syndromes (1)
Stage: All stages (1) Approved / Phase 4 (0) Phase 3 / Filed (1) Phase 2 Phase 1 / Preclinical
Quick filter: All (1) Chronic Kidney Disease (1) Myelodysplastic Syndromes (1)
Showing 1 of 1 assets
Asset ↕ Stage ↓ Target & Modality Disease / Indication ↕ Phase 3 HIF prolyl hydroxylase (HIF-PH1/2/3) Small molecule
Chronic Kidney Disease Myelodysplastic Syndromes
Upcoming events (6 total) Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Add these trial readouts to your calendar: Apple or Outlook · Google Calendar · .ics link . The calendar updates when a registry date moves.
2026 (2) December 2026 (2) AND017 Phase 2 β -Thalassemia Est. primary completion 2026-12 ·
NCT06302491 ·
CT.gov ↗ What to watch
AND017 Phase 2 Myelodysplastic Syndromes Est. primary completion 2026-12 ·
NCT06304103 ·
CT.gov ↗ What to watch
2027 (3) February 2027 (1) AND017 Phase 3 Anemia Due to Chronic Kidney Disease Est. primary completion 2027-02-20 ·
NCT07494409 ·
CT.gov ↗ What to watch
March 2027 (1) AND017 Phase 3 Anemia Due to Chronic Kidney Disease Est. primary completion 2027-03-01 ·
NCT07487727 ·
CT.gov ↗ What to watch
December 2027 (1) AND017 Phase 2 Chemotherapy Induced Anemia Est. primary completion 2027-12 ·
NCT06075030 ·
CT.gov ↗ What to watch
2028 (1) May 2028 (1) AND017 Phase 2 Cancer-Related Anemia Est. primary completion 2028-05 ·
NCT06075043 ·
CT.gov ↗ What to watch
See the full readout calendar ↗
Financial reports No financial reports recorded.